Business intelligence represents an essential element of any business-related venture, no matter the location or industry. These days, data gathering, and analysis are the foundation of businesses and no longer just an accessory.
In 2006 Clive Humby coined term "data is the new oil". Much like oil, data is an invaluable resource, but without refinement it is useless. In 2021 we saw an opportunity to fill this gap in biotech market analysis.
While currently available databases are either too heterogenous or overly expensive, none are homogenous and precise, containing only the information of interest, without all the data noise. Many of these reports contain unnecessary information, that confuse the customer more than it helps, while being mixed with technologies and approaches.
With Stargazing Bio Research, we sought to remedy these issues. We are producing the next generation of biotech business intelligence. Our disentangled and accurate databases let you get the full overview of relevant markets and technologies, without the bloat of conventional biotech company lists.
Knowledge is key
If you want an edge in the competitive landscape of biotech and biotech investing, you need absolute knowledge of the companies involved in these fields and how they are involved. Mapping out your company or investment against the competition will be what sets you apart from the ones around you.
Knowledge of the state-of-the-art within your focus area is essential to great investing, whether you are a private investor or a company. At Stargazing Bio Research we have developed a cutting edge method of database generation ensuring strictly quality controlled content.
We stand by the fact that the biotech company databases we create have the highest homogeneity of any bio-research company out there. No where else will you find the amount of precision and complete data that we provide here.
Should you want to learn more about the company, the databases or even make a request, make sure to reach out to us.